Decoy Therapeutics Inc.
corporate_fare Company Profile
Decoy Therapeutics Inc. (NASDAQ:DCOY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for DCOY at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Decoy Therapeutics Finalizes 1-for-12 Reverse Stock Split to Maintain Nasdaq Listing
- Stockholders Approve Reverse Stock Split and New Equity Incentive Plan
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$12.52M
Diluted EPS
-$129.10
Op. Cash Flow
-$4.83M
Free Cash Flow
-$5.4M
Operating Income
-$12.61M
Cash & Equivalents
$10.71M
Debt / Equity
0.00×
Shares Outstanding
96.97K sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-195909
show_chartPrice Chart
Loading chart...